TMD chronic pain and masseter silent period in psychiatric patients on antidepressive therapy

Journal of Oral Rehabilitation

Volumn 35, Issue 6, 2008, Pages 424-432

  Ivkovic, N ^a   Mladenovic, I ^a   Petkovic, S ^b   Stojic, D ^c  

^a UNIVERSITY OF EAST SARAJEVO   (Bosnia and Herzegovina)

^b UNIVERSITY OF DEFENCE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Antidepressive therapy; Chronic pain; Masseter silent period; Psychiatric patients; Temporomandibular disorders

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; DIAZEPAM; MAPROTILINE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CASE CONTROL STUDY; CHRONIC DISEASE; DRUG COMBINATION; ELECTROMYOGRAPHY; FACE PAIN; FEMALE; HUMAN; MALE; MASSETER MUSCLE; MENTAL DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; TEMPOROMANDIBULAR JOINT DISORDER;

ADULT; ANALYSIS OF VARIANCE; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; CHRONIC DISEASE; DIAZEPAM; DRUG THERAPY, COMBINATION; ELECTROMYOGRAPHY; FACIAL PAIN; FEMALE; HUMANS; MALE; MAPROTILINE; MASSETER MUSCLE; MENTAL DISORDERS; MIDDLE AGED; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 43049129229     PISSN: 0305182X     EISSN: 13652842     Source Type: Journal    
DOI: 10.1111/j.1365-2842.2007.01819.x     Document Type: Article

References (43)

1. Nassif NJ, Al-Salleeh F, Al-Admawi K. The prevalence and treatment needs of symptoms and signs of temporomandibular disorders among young adult males. J Oral Rehabil. 2003 30 : 944 950.
2. Kirveskari P. Prediction of demand for treatment of temoporomandibular disorders. J Oral Rehabil. 2001 28 : 572 575.
3. Pedroni CR, DeOliveira AS, Guaratini MI. Prevalence study of signs and symptoms of temporomandibular disorders in university students. J Oral Rehabil. 2003 30 : 283 289.
4. Okeson JP. Management of temporomandibular disorders and occlusion, 5th edn. St Louis : Mosby 2003.
5. Phillips JM, Gatchel RJ, Wesley L, Ellis E. Clinical implications of sex in acute temporomandibular disorders. J Am Dent Assoc. 2001 132 : 49 57.
6. Dworkin SF. Perspectives on the interaction of biological, psychological and social factors in TMD. J Am Dent Assoc. 1994 125 : 856 862.
7. Kight M, Gatchel RJ, Wesley LV. Temporomandibular disorders: Evidence for significant overlap with psychopathology. Health Psychol. 1999 18 : 177 182.
8. Eversole LR, Stone CE, Matheson D, Kaplan H. Psychometric profiles and facial pain. Oral Surg Oral Med Oral Pathol. 1985 60 : 269 274.
9. Lundeen TF, Sturdevant JR, George JM. Stress as a factor in muscle and temporomandibular joint pain. J Oral Rehabil. 1987 14 : 447 452.
10. Dionne RA. Pharmacologic treatments for temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 83 : 134 142.
11. Plesh O, Curtis D, Levine J, McCall WD. Amitriptyline treatment of chronic pain in patients with temporomandibular disorders. J Oral Rehabil. 2000 27 : 834 841.
12. Stohler CS. Management of persistent orofacial pain. In : Lund JP, Lavigne GJ, Dubner R, Sessle BJ, eds. Orofacial pain: from basic science to clinical menagement. Chicago : Quintessence Publishing Co 2001.
13. Haas DA. Pharmacologic considerations in the management of temporomandibular disorders. J Can Dent Assoc. 1995 61 : 105 109.
14. Keene JJ, Galasko GT, Land MF. Antidepressant use in psychiatry and medicine. J Am Dent Assoc. 2003 134 : 71 79.
15. Fogelholm R, Murros K. Maprotiline in chronic tension headache: a double-blind cross-over study. Headache: The Journal of Head and Face Pain. 1985 25 : 273 275.
16. Atkinson JH, Slater MA, Wahlgren DR, Williams RA, Zisook S, Pruitt SD et al. Effect of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain. 1999 83 : 137 145.
17. Ganzberg S, Quek SYP. Pharmacotherapy. In : Pertes RA, Gross SG eds. Clinical management of temporomandibular disorders and orofacial pain, Chapter 13, 1st edn. Chicago : Quintessence Publishing Co 1995.
18. Singer EJ, Sharav Y, Dubner R, Dionne RA. The efficacy of diazepam and ibuprofen in the treatment of chronic myofascial orofacial pain. Pain. 1987 4 : S83.
19. Harkins S, Linford J, Cohen J, Kramer T, Cueva L. Administration of clonazepam in the treatment of TMD and associated myofascial pain: a double-blind pilot study. J Craniomand Disord. 1991 5 : 179 186.
20. McCall WD, Hoffer M. Jaw muscle silent periods by tooth tap and chin tap. J Oral Rehabil. 1981 8 : 91 96.
21. Skiba T, Laskin DM. Masticatory muscle silent period in patients with MPD syndrome before and after treatment. J Dent Res. 1981 60 : 699 706.
22. Liu ZJ, Yamagata K, Kasahara Y, Ito G. Electromyographic examination of jaw muscles in relation to symptoms and occlusion of patients with temporomandibular joint disorders. J Oral Rehabil. 1999 26 : 33 47.
23. Bendtsen L, Jensen R, Olesen J. Amitriptyline, a combined serotonin and noradrenaline re-uptake inhibitor, reduces exteroceptive supresion of temporal muscle activity in patients with chronic tension-type headache. Electroencephalogr Clin Neurophysiol. 1996 101 : 418 422.
24. Cruccu G, Inghilleri M, Fraioli B, Guidetti B, Manfredi M. Neurophysiological assessment of trigeminal function after surgery for trigeminal neuralgia. Neurology. 1987 37 : 631 638.
25. DeLaat A, van der Glas HW, Weytjens JLF, van Steenberghe D. The masseteric poststimulus EMG complex in people with dysfunction of the mandibular joint. Arch Oral Biol. 1985 30 : 177 180.
26. Hanson B, Sherman R, Ficara A. Masseter muscle silent period in patients with internal derangement of the temporomandibular joint before and after splint therapy. J Prosth Dent. 1985 54 : 846 850.
27. Zulqarnain BJ, Furuya R, Hedegard B, Magnusson T. The silent period in the masseter and the anterior temporalis muscles in adult patients with mild or moderate mandibular dysfunction symptoms. J Oral Rehabil. 1989 16 : 127 137.
28. World Health Organisation. The ICD-10. Classification of mental and behavioural disorders: clinical description and diagnostic guidelines. Geneva : World Health Organisation 1992.
29. Helkimo M. Studies on function and dysfunction of the masticatory system II. Index for anamnestic and clinical dysfunction and occlusal state. Swed Dent J. 1974 67 : 101 164.
30. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders. J Craniomandib Disord: Facial and Oral Pain. 1992 6 : 301 355.
31. Wang K, Svensson P, Arendt-Nielsen L. Modulation of exteroceptive suppression periods in human jaw-closing muscles by local and remote experimental muscle pain. Pain. 1999 82 : 253 262.
32. Schiffman E, Fricton JR, Haley D, Shapiro BL. The prevalence and treatment needs of subjects with temporomandibular disorders. J Am Dent Assoc. 1990 120 : 295 303.
33. Yap AUJ, Chua EK, Hoe JKE. Clinical TMD, pain-related disability and psychological status of TMD patients. J Oral Rehabil. 2002 29 : 374 380.
34. NIH. National Institutes of Health Technology Assessment Conference Statement: Management of temporomandibular disorders, April 29-May 1, 1996. Oral Med Oral Pathol Oral Radiol Endod. 1997 83 : 177 183.
35. Sharav Y, Singer E, Schmidt E, Dionne RA, Dubner R. The analgesic effect of amitriptyline on chronic facial pain. Pain. 1987 31 : 199 209.
36. Herman CR, Schiffman EL, Look JO. The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patients education and self-care for the treatment of jaw pain upon awakening: a randomized clinical trial. J Orofac Pain. 2002 16 : 64 70.
37. Godaux E, Desmedt JE. Exteroceptive suppression and motor control of the masseter and temporalis muscles in normal man. Brain Res. 1975 85 : 447 458.
38. Widmalm S. The silent period in the masseter of patients with TMJ dysfunction. Acta Odontol Scand. 1976 34 : 43 52.
39. Schoenen J, Jamatr B, Gerard P, Lenarduzzi P, Delwaide PJ. Exteroceptive suppression of temporalis muscle activity in chronic headache. Neurology. 1987 37 : 1834 1836.
40. Cruccu G, Fridsardi G, Pauletti G, Romaniello A, Manfredi M. Excitability of the central masticatory pathways in patients with painful temporomandibular disorders. Pain. 1997 73 : 447 454.
41. Rudolph U, Crestani F, Benke D. Benzodiazepine actions mediated by specific gamma-aminobutyric acid receptor subtypes. Nature. 1999 401 : 796 800.
42. Kossioni AE, Karkazis HC. The influence of the gender on the masseter electromyographic jaw-jerk reflex in young human subjects. J Oral Rehabil. 1994 21 : 419 430.
43. Komiyama O, Wang K, Svensson P, Arendt-Nielsen L, Delaat A. Gender difference in masseteric exteroceptive suppression period and pain perception. Clin Neurophysiol. 2005 116 : 2599 2605.